文献速递造血干细胞移植与细胞治疗

胃泌素治疗胃急性移植物抗宿主病

Gastrin for the treatment of acute graft-versus-host disease of the stomach.
PubMed 文献 · Blood · 2026-01-01

该研究探讨肠内分泌激素胃泌素对胃急性GVHD的组织保护作用。小鼠实验显示五肽胃泌素可恢复壁细胞、正常化胃pH并增加LGR5+细胞,胃泌素缺失小鼠GVHD更重;患者胃活检低胃泌素水平与生存降低相关,为临床试验提供依据。

要点

  • 胃aGVHD导致产胃泌素G细胞和壁细胞丢失、胃pH升高。
  • 五肽胃泌素可挽救aGVHD小鼠壁细胞丢失并正常化胃pH。
  • 患者胃活检低胃泌素水平与生存降低及aGVHD严重度相关。

核心结论

  • 胃泌素在胃aGVHD中发挥保护作用,五肽胃泌素具有临床 Trial 治疗aGVHD的合理依据。

研究设计与样本

  • 小鼠aGVHD模型结合患者胃活检样本的转化研究,比较五肽胃泌素处理与对照及Gast-/-小鼠。

主要发现

  • aGVHD导致产胃泌素G细胞和壁细胞丢失、胃pH升高及供者T细胞浸润胃壁。
  • 五肽胃泌素处理aGVHD小鼠可挽救壁细胞丢失、正常化胃pH、增加胃干细胞标志物表达及LGR5+细胞丰度。
  • 胃泌素在体外增加胃和小肠类器官活力。
  • Gast-/-小鼠肠道和肝脏aGVHD较野生型更重,五肽胃泌素可挽救。
  • 患者胃活检低胃泌素水平与生存降低相关,胃泌素表达与aGVHD严重度及组织损伤评分相关。

临床怎么用

  • 胃aGVHD患者胃活检胃泌素水平可能有助于风险评估。
  • 五肽胃泌素可作为aGVHD临床试验的候选治疗药物。

局限性

  • 研究以小鼠模型为主,患者数据为观察性关联,尚需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute graft-versus-host disease (aGVHD) is a major cause of death after allogeneic hematopoietic cell transplantation, and patients with steroid-refractory aGVHD have a dismal prognosis. We have previously shown that the enteroendocrine hormone glucagon-like peptide-2 has tissue regenerative activity in the lower gastrointestinal tract in mice and patients with steroid-refractory aGVHD. Here, we explored the tissue protective effect of the enteroendocrine hormone gastrin for aGVHD of the stomach. We observed that aGVHD caused a loss of gastrin-producing G-cells and parietal cells (PCs) and an increase in pH in the stomach, and allogeneic T cells had infiltrated the stomach wall. Pentagastrin treatment of aGVHD mice rescued the loss of PCs, normalized the pH in the stomach, increased stomach stem cell marker expression and abundance of LGR5+ cells. Gastrin also increased the viability of stomach and small intestine organoids in vitro. Compared with wild-type mice, Gast-/- mice experienced more severe aGVHD in the intestine and liver, which was rescued by pentagastrin treatment. In patients developing aGVHD, low gastrin levels in stomach biopsies were connected to reduced survival. Moreover, gastrin expression in the stomach correlated with aGVHD severity and tissue damage scores in independent patient cohorts. This study delineates the protective role of gastrin in aGVHD of the stomach in mice and patients and provides a rationale for the therapeutic use of pentagastrin in a clinical trial of patients with aGVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Gawron J, Czech M, Rückert T, et al. Gastrin for the treatment of acute graft-versus-host disease of the stomach. Blood. 2026. PMID: 41511880. doi:10.1182/blood.2025031080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。